Back to AMERIPRISE FINANCIAL INC AMERIPRISE FINANCIAL INC

RYTMRYTM
Showing 8 of 22 quarters

Position history for AMERIPRISE FINANCIAL INCAMERIPRISE FINANCIAL INC's holdings in RHYTHM PHARMACEUTICALS INC

AMERIPRISE FINANCIAL INC holds 401,634 shares of RYTM (RHYTHM PHARMACEUTICALS INC), worth $44.6M as of 2026-Q2. The position was increased (+4.6% shares). RYTM represents 0.0% of AMERIPRISE FINANCIAL INC's portfolio.

Current Value

$44.6M

Current Shares

401,634

Total Value Change

+$42.4M

Total Shares Change

+359,747

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
401,634
+4.6%
$44.6M0.0%$111.03
31
2026-Q1
Increased
383,957
+47.0%
$33.4M0.0%$89.56
40
2025-Q4
Increased
261,160
+89.3%
$28M0.0%$106.76
45
2025-Q3
Decreased
137,967
-20.3%
$13.9M0.0%$100.64
0
2025-Q2
Increased
173,069
+76.1%
$10.9M0.0%$62.73
42
2025-Q1
Increased
98,281
+84.2%
$5.2M0.0%$54.80
42
2024-Q4
Increased
53,367
+27.4%
$3M0.0%$56.34
33
2024-Q3
Increased
41,887
+3.6%
$2.2M0.0%$51.35
27

Other major holders of RYTM: RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used